Log in to save to my catalogue

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing...

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_97807982449d429dbc05a64bad75bfbb

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

About this item

Full title

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

Publisher

London: BioMed Central Ltd

Journal title

Clinical epigenetics, 2023-10, Vol.15 (1), p.1-171, Article 171

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Acute myeloid leukemia (AML) is a heterogeneous disease with a poor prognosis. Dysregulation of the epigenetic machinery is a significant contributor to disease development. Some AML patients benefit from treatment with hypomethylating agents (HMAs), but no predictive biomarkers for therapy response exist. Here, we investigated whether u...

Alternative Titles

Full title

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_97807982449d429dbc05a64bad75bfbb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_97807982449d429dbc05a64bad75bfbb

Other Identifiers

ISSN

1868-7083,1868-7075

E-ISSN

1868-7083,1868-7075

DOI

10.1186/s13148-023-01580-z

How to access this item